You must be 21 years of age or older to enter Curo. Products and information on this site are intended for laboratory research use only and are not for human or animal use.
Research-use material
Metabolic & Performance$124
A long-acting amylin analogue studied for satiety signaling, appetite, body-weight regulation, and metabolic research.
For laboratory research use only. Not for human or animal consumption.
Cagrilintide is a lipidated, long-acting analogue of amylin, a pancreatic hormone involved in satiety and energy balance. It activates amylin and calcitonin receptors rather than the GLP-1 receptor.
Research focuses on how this receptor system influences food intake and body-weight regulation. Cagrilintide has been studied on its own in randomized human trials, and separately as the amylin component of CagriSema alongside semaglutide.
Dedicated phase 3 studies are underway, but cagrilintide remains investigational and is not FDA-approved.
This set includes one CJC-1295 no DAC compound and one Ipamorelin compound. Each compound is packaged separately and is not pre-mixed.
A GHRH-analog and selective-secretagogue pairing, studied together for a larger combined growth-hormone pulse than either compound produces alone.